AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CEFOPERAZONE + SULBACTAM

9 registrations across 4 African markets— 7 active

Markets with CEFOPERAZONE + SULBACTAM

Recent registrations

Brand / ProductMarketHolderStatusExpires
BACPERAZONE 500MG/500MG POUDRE POUR DSOLUTION INJECTABLE EN IM/IV BOITE DE 1🇨🇮Côte d'IvoireGEPACH INTERNATIONALexpiredJan 2021
BACPERAZONE 1G/1G POUDRE POUR SOLUTION INJECTABLE EN IM/IV BOITE DE 1🇨🇮Côte d'IvoireGEPACH INTERNATIONALexpiredJan 2021
ELEVA PLUS
solution injectable / 500 mg / 500 mg
🇸🇳SenegalWILSHIRE LABORATORIESactive
CEFOPERAZONE + SULBACTAM
PARENTERAL ORDINARY DRY VIALS
🇺🇬UgandaCADILA PHARMACEUTICA LS LIMITEDactive
SEFOZ-S 2000 PPI IM/IV COMBIPACK FL(1G+1MG) + EAU P.I(10ML)
flacon de 1G + 1G de poudre
🇲🇬MadagascarSKS LABORATOIRESactive
CEFOPERAZONE + SULBACTAM
PARENTERAL ORDINARY DRY VIALS
🇺🇬UgandaCADILA PHARMACEUTICA LS LIMITEDactive
MAGTAM
poudre pour préparation injectable / 1000 mg
🇸🇳SenegalALKEM LABORATORIES LIMITEDactive
SEFOZ-S 2000 PPI IM/IV COMBIPACK FL(1G+1MG) + EAU P.I(10ML)
flacon de 1G + 1G de poudre
🇲🇬MadagascarSKS LABORATOIRESactive
ELEVA PLUS
solution injectable / 1000 mg / 1000 mg
🇸🇳SenegalWILSHIRE LABORATORIESactive

CEFOPERAZONE + SULBACTAM in Africa — Regulatory Overview

CEFOPERAZONE + SULBACTAM is registered across 4 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Côte d'Ivoire, Madagascar, Uganda. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 7 (78%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.